The Allstate Corporation

**Analysis of The Allstate Corporation (ALL)**

Technical Analysis: ALL shows strong defensive characteristics with low volatility (beta of 0.24) and is trading near its 52-week high, indicating positive momentum. While it has recently underperformed the broader market, its modest maximum drawdown suggests it is not overbought, presenting a stable technical setup for risk-averse investors.

Fundamentals: The company exhibits robust profitability, with a net margin of 23.1% and improving gross margins. Financial health is solid, underscored by a low debt-to-equity ratio of 0.24 and strong interest coverage. Although asset turnover is low, the high return on equity of 12.5% reflects efficient use of shareholder capital.

Valuation: ALL appears significantly undervalued, with a forward P/E of just 3.55 and a reasonable price-to-book ratio of 1.78. The low earnings multiples, combined with a solid EV/EBITDA of 11.95, suggest the stock is priced at a discount to its earnings potential, offering a compelling entry point.

Risk: Risk is relatively low, given the stock’s low beta and contained maximum drawdown of -14.11%. The absence of significant short interest further reduces near-term downside pressure, reinforcing its defensive profile.

**Investment Recommendation**

ALL presents a compelling buy opportunity for investors seeking a stable, undervalued stock with defensive qualities. Its strong fundamentals, conservative financials, and low volatility are paired with deeply discounted valuation metrics. While growth may be modest, the risk-reward profile is attractive for long-term, income-oriented portfolios.

RockFlow Model Forecast: Three Scenarios for 2026

Based on the comprehensive analysis, the 12-month outlook for The Allstate Corporation (ALL) is positive, driven by its compelling valuation and defensive characteristics. Key catalysts include the realization of its significant earnings-based undervaluation (forward P/E of 3.55) and continued strong profitability, which could attract value-focused investors seeking stability. The primary risk is modest growth potential, as a low asset turnover may limit top-line expansion, keeping returns steady but not explosive. Considering its strong fundamentals and discounted valuation, a reasonable 12-month target price range could be $240 - $260, implying a potential upside of approximately 13-22% from the current price.

Wall Street Consensus

Most Wall Street analysts are optimistic about The Allstate Corporation's 12-month outlook, with consensus target around $214.52, indicating expected upside potential.

Overall, ALL has investment potential but also faces challenges. Here are key factors to weigh before investing.

ALL has demonstrated modest positive performance over recent periods while showing notably low volatility characteristics. The stock's beta of 0.235 indicates substantially lower volatility than the broader market.

Short-term performance shows strong recent momentum with a 9.24% one-month gain, though three-month performance remains essentially flat at 0.48%. Despite this recent strength, ALL has underperformed the market by -5.15% over the three-month period, highlighting its defensive positioning.

Currently trading at $212.76, ALL sits near the upper end of its 52-week range, approximately 2% below its $216.75 high. While the stock is approaching recent resistance levels, its modest beta and -14.11% maximum drawdown suggest it remains within reasonable valuation parameters rather than being significantly overbought.

Revenue & Profitability The company demonstrated strong profitability in Q4 2025 with a net profit margin of 23.1%, an improvement from the prior quarter's 22.0%. This enhancement was driven by a significant expansion in the gross profit margin to 53.0%, up from 36.6% in Q3, indicating improved cost control or a favorable shift in the revenue mix.

Financial Health ALL maintains a very conservative capital structure, evidenced by a low debt-to-equity ratio of 0.24 and a robust interest coverage ratio of 50.2. The cash flow situation is solid, with operating cash flow comfortably covering debt obligations, as reflected in a cash flow to debt ratio of 0.40.

Operational Efficiency Operational efficiency appears efficient, with a strong return on equity of 12.5% for the period. However, the asset turnover ratio of 0.14 suggests that the company generates a relatively modest level of revenue relative to its asset base, which is a characteristic of capital-intensive industries.

Based on the provided valuation metrics, ALL appears significantly undervalued. The TTM and Forward P/E ratios of 5.32 and 3.55, respectively, are exceptionally low, suggesting the market prices the stock at a deep discount to its current and near-future earnings. While the PEG ratio above 1.0 indicates some premium for expected growth, the strong cash flow generation implied by the EV/EBITDA of 11.95 and the moderate price-to-book of 1.78 further support an attractive valuation profile.

A peer comparison cannot be conclusively performed due to the unavailability of industry average data. However, the extremely low P/E ratios would typically be considered deeply discounted in most market sectors, particularly when combined with a reasonable premium for growth as indicated by the PEG ratio. Therefore, this valuation level strongly suggests undervaluation relative to the broader market, though a precise industry ranking is not possible.

Based on the provided metrics, ALL exhibits low volatility risk relative to the broader market. With a Beta of 0.235, the stock is theoretically only about 23.5% as volatile as the market, indicating it tends to be far less sensitive to broad market swings. The moderate 1-year maximum drawdown of -14.11% further supports this characterization, suggesting that while investors have experienced losses during market downturns, the magnitude of these declines has been relatively contained for a single stock.

Other risks appear to be minimal based on the available data. The absence of reported short interest suggests that sophisticated investors do not currently hold a significant negative view of the company's near-term prospects, which reduces the risk of a short squeeze or concentrated selling pressure. Furthermore, while specific liquidity metrics are not provided, the lack of short interest often implies a healthier, more balanced market for the stock, potentially lowering transaction cost risks.